Portfolio Design Labs’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
50,289
+3,568
+8% +$93.3K 0.2% 98
2026
Q1
$1.31M Sell
46,721
-9,943
-18% -$265K 0.23% 88
2025
Q4
$1.41M Buy
56,664
+1,119
+2% +$28.2K 0.23% 108
2025
Q3
$1.42M Buy
+55,545
New +$1.37M 0.24% 106
2025
Q2
Sell
-16,088
Closed -$408K 184
2025
Q1
$408K Buy
+16,088
New +$421K 0.08% 135

Other funds holding PFE

Portfolio Design Labs's PFE Position: Q2 2026 in Review

Portfolio Design Labs increased its Pfizer (PFE) stake by 7.6% in Q2 2026, buying an estimated $93.3K and bringing the position to 50,289 shares worth $1.21M. The position accounts for 0.2% of the portfolio, ranked #98.

Portfolio Design Labs first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.42M in Q3 2025. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Portfolio Design Labs held 50,289 shares of Pfizer worth $1.21M as of Q2 2026.
  • Portfolio Design Labs bought 3,568 Pfizer shares in Q2 2026, an estimated $93.3K.
  • Pfizer made up 0.2% of Portfolio Design Labs's portfolio in Q2 2026, its #98 holding.
  • Portfolio Design Labs first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
  • Portfolio Design Labs's Pfizer position peaked at $1.42M in Q3 2025.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.